about
Collaborative science in the next-generation sequencing era: a viewpoint on how to combine exome sequencing data across sites to identify novel disease susceptibility genes.The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk.Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast CancerThe serum protein profile of early parity which induces protection against breast cancer.A Recurrent ERCC3 Truncating Mutation Confers Moderate Risk for Breast Cancer.A Breast Tissue Protein Expression Profile Contributing to Early Parity-Induced Protection Against Breast Cancer.Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing.
P50
Q30992909-1E5E660F-D5D9-41FD-9351-6DBB98844F8AQ33784408-8EA8FDF5-FF96-4C6E-BD68-EF4F6F1C5D5CQ36890898-5006E331-7DD3-46CB-89B7-DF43B57C0413Q37696172-2671B787-36AF-48FF-90F7-7CF32CA06C6CQ40495288-93F8193D-D4E1-41CD-993E-3624290AB515Q42484645-0E688651-02EE-4016-91C1-353EB3E88F27Q50222046-707A44B2-E4FB-4900-ACA8-010A4CABB4A9
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Vignesh Ravichandran
@ast
Vignesh Ravichandran
@en
Vignesh Ravichandran
@es
Vignesh Ravichandran
@nl
Vignesh Ravichandran
@sl
type
label
Vignesh Ravichandran
@ast
Vignesh Ravichandran
@en
Vignesh Ravichandran
@es
Vignesh Ravichandran
@nl
Vignesh Ravichandran
@sl
prefLabel
Vignesh Ravichandran
@ast
Vignesh Ravichandran
@en
Vignesh Ravichandran
@es
Vignesh Ravichandran
@nl
Vignesh Ravichandran
@sl
P106
P31
P496
0000-0002-1532-2593